Brief: Centessa Pharmaceuticals Q3 Loss Per Share $0.45
Nov 15 (Reuters) - Centessa Pharmaceuticals PLC 260y.F :
* Q3 LOSS PER SHARE $0.45
Source text for Eikon: ID:nGNX6rhxd7
Further company coverage: 260y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Centessa Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1